Empire State Development Strategic Plan
This document outlines Empire State Development's comprehensive strategic approach to foster and support the growth of the biotech and life sciences sector in New York State. It details initiatives across various divisions, including New York Ventures for capital investment, NYSTAR for innovation and manufacturing support through grants, and the Life Sciences R&D Tax Credit Program. Key strategic focus areas include accelerating the translation of research to market, leveraging artificial intelligence and robotics for drug discovery through Excelsior Sciences, and positioning the state as a global leader in cell and gene therapy. The ultimate goal, as informed by an updated strategic plan from 2023, is to ensure life-changing discoveries are invented, commercialized, manufactured, and scaled within New York, thereby creating jobs and economic benefits.